STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY Dragan Kesič∗ Received: 28. 2. 2007 Case study Accepted: 9. 7. 2008 UDC 65.01:615 The world pharmaceutical industry has been changing profoundly in the last decade. Intensive globalization‚ increased competitiveness and the fight for global market shares create new challenges for pharmaceutical companies. Fast globalization definitively reinforces the consolidation of the world pharmaceutical industry. Alliancing in forms of mergers and
Premium Pharmaceutical industry Generic drug Marketing
Mobile Marketing: Making a Good Connection Though the practice of mobile marketing is still in its infancy‚ the budding channel carries outsized expectations. But the ability to reach people anytime‚ anywhere‚ must be weighed carefully against the potential for irritating people and damaging brand relationships. How can marketers harness the power of this nascent medium to drive growth for their brands? M I L L W A R D A u g u s t 2 0 0 6 B R O W N ’ S P O V According to The Shosteck
Premium Mobile phone Advertising Text messaging
INTRODUCTION This essay would inquire in to the impact of global health actors on Health Policies in the Republic of Ghana highlighting the World Trade Organization‚ The World Bank and the International Monetary Fund as reference points. Policy issues have emerged from both constructive and unconstructive effects of various global processes associated with development in the trans-national movement of funds‚ commodities‚ services‚ a rise in multinational corporations‚ widening inequalities‚ diseases
Premium Medicine World Bank Policy
Amsterdam‚ the Leiden University Medical Center‚ the University Medical Center Nijmegen‚ the University Medical Center‚ University of Groningen‚ the VU University Medical Center‚ Amsterdam. Publication of this thesis was financially supported by: GlaxoSmithKline‚ Amgen B.V. Breda‚ Roche Nederland B.V.‚ Siemens Nederland B.V.‚ AstraZeneca © Mieke Kriege 2006 No part of this publication may be reproduced‚ stored in a retrieval system or transmitted in any form or by any means‚ electronic‚ mechanical‚ photocopying
Premium Cancer
Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
OEDZGE ATZEMA‚ EGBERT WEVER AND MARLOES KROL 186 10 Product upgrading and survival: the case of VW Navarra MARTINA FUCHS 216 11 The demise of a local champion: MacMillan Bloedel’s acquisition by Weyerhaeuser ROGER HAYTER 234 12 GlaxoSmithKline: regional and local networking in a post-communist economy TADEUSZ STRYJAKIEWICZ 260 13 Epilogue: a relational perspective PETER DICKEN 276 Index 284 Illustrations Figures 1.1 1.2 1.3 1.4 1.5 2.1 2.2 2.3 2.4 2.5 2.6 2
Premium Economic geography Geography
The relationship between democracy and economic growth has long been debated over the years and the emergence and continued rise of China as an economic powerhouse not only in the Asia-Pacific region but in the world has further intensified this debate considering China’s democratic credentials. This essay will assess the arguments surrounding the extent to which democracy as a political system can be considered to be a pre-requisite to economic growth from a global perspective by mainly using China
Premium Democracy Economics
Content: 1- Introduction 2- Definitions 3- Review of the learning Organization 4- Review of the Knowledge Management 1- Introduction Learning organizations are not simply the most fashionable or current management trend‚ they can provide work environments that are open to creative thought‚ and embrace the concept that solutions to ongoing work-related problems are available inside each and every one of us. All we must do is tap into the knowledge base‚ which gives
Premium Knowledge management Management
Balance Sheet The biggest change in Abbott’s balance sheet can be seen in the composition of its asset accounts. In 2006‚ % of the firm’s assets were current‚ while 69% were of the long-term variety. In 2010‚ however‚ the portion of current assets increased by 7%. This increase in current assets is most visible in cash and short-term investments (4% in 2006 to 9% in 2010) and corresponds with a higher level of uncertainty in today’s economy. The fact that Abbott Laboratories has chosen to increase
Premium Financial ratios Balance sheet Financial ratio
Pfizer ’s SWOT Analysis MGT/521 June 8‚ 2011 Professor Craig Clark Pfizer ’s SWOT Analysis Pfizer has come a long way since its modest beginnings in 1849‚ when it founded by cousins‚ Charles Pfizer and Charles Erhart and their sole product was citric acid‚ which would lead to the development of penicillin. Today Pfizer is the world’s largest research-based pharmaceutical company. The company consists of three Strategic Business Units: Health Care‚ Animal Health‚ and Consumer Health Care
Premium Marketing SWOT analysis